Long‐term outcomes of diabetic patients suffering from ST‐segment elevation myocardial infarction (STEMI) and treated with second‐generation drug‐eluting stent have been scarcely evaluated. The aim of this posthoc subanalysis of the… Click to show full abstract
Long‐term outcomes of diabetic patients suffering from ST‐segment elevation myocardial infarction (STEMI) and treated with second‐generation drug‐eluting stent have been scarcely evaluated. The aim of this posthoc subanalysis of the EXAMINATION trial was to compare 5‐year outcomes according to the presence of diabetes mellitus.
               
Click one of the above tabs to view related content.